Meta-Analysis Shows Prevalence of Statin Intolerance Is Low
WEDNESDAY, Feb. 16, 2022 (HealthDay News) -- The prevalence of statin intolerance (SI) is low, according to a meta-analysis published online Feb. 15 in the European Heart Journal.
Ibadete Bytyçi, from Umeå University in Sweden, and colleagues conducted a meta-analysis to estimate the overall prevalence of SI and factors that might increase the risk for SI. Data were included from 176 studies (112 randomized controlled trials [RCTs] and 64 cohort studies) with 4,143,517 patients.
The researchers found that the prevalence of SI was 9.1 percent overall and was similar when defined using the National Lipid Association, International Lipid Expert Panel, and European Atherosclerosis Society diagnostic criteria (7.0, 6.7, and 5.9 percent, respectively). The prevalence of SI was significantly lower in RCTs versus cohort studies (4.9 versus 17 percent). In studies including both primary and secondary prevention patients, the prevalence of SI was much higher than with a separate analysis of primary or secondary prevention patients (18 percent versus 8.2 and 9.1 percent, respectively). The prevalence of SI was not affected by statin lipid solubility. In the meta-regression model, significant associations with SI were seen for age, female gender, Asian and Black race, obesity, diabetes mellitus, hypothyroidism, chronic liver, and renal failure. An increased risk for SI was also seen in association with antiarrhythmic agents, calcium channel blockers, alcohol use, and increased statin dose.
These results "show that in most cases statin intolerance is over-estimated and over-diagnosed, and they mean that around 93 percent of patients on statin therapy can be treated effectively, with very good tolerability and without any safety issues," a coauthor said in a statement.
Several authors disclosed financial ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Related Posts
AHA News: Este procedimiento de extracción de coágulos parece ser seguro en pacientes embarazadas que han padecido un ataque cerebral
LUNES, 20 de septiembre de 2021 (American Heart Association News) -- Extraer...
Missed Nursing Care Tied to Poor Outcomes for Very Low Birth Weight Infants
MONDAY, Feb. 13, 2023 (HealthDay News) -- For very low birth weight (VLBW)...
Weight Gain During Pregnancy: An Ob-Gyn Shares What You Need to Know
Pregnancy is a time filled with excitement and anticipation. While there are...
Women With PCOS Face Twice the Odds for Ovarian Cancer After Menopause
TUESDAY, June 27, 2023 (HealthDay News) -- The risk for ovarian cancer among...